Clinical Trial Update: Study to Evaluate SC Route of Administration of Ofatumumab in RA Patients [Phase 1]

View source ↗

Summary

A completed Phase 1 study evaluating subcutaneous administration of ofatumumab in rheumatoid arthritis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Ofatumumab (ofatumumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Arthritis, Rheumatoid | Phase 1 | Status: COMPLETED